Sarah Smith
Medical · Philadelphia, PANPI 1912026832
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $47,175 of the $65,079 with a category attached, or 72.5%. 15 manufacturers reported payments, led by Gilead at 35.5% of the total. Among medical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $276.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$23K
- Viiv Healthcare Company$19K
- Janssen Products, LP$14K
- Merck$8K
- Johnson & Johnson$457
- AbbVie$380
- plus $328 from 9 others
What the payments were for
- Consulting fees$6,84011%
- Speaking & faculty fees$47,17572%
- Travel & lodging$6,65910%
- Food & beverage$4,1456%
- Education$2600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 61 | $23,126 |
| Viiv Healthcare Company | 82 | $18,822 |
| Janssen Products, LP | 18 | $13,976 |
| Merck | 23 | $7,989 |
| Johnson & Johnson(2 entities) | 26 | $457 |
| AbbVie | 9 | $380 |
| Exact Sciences | 4 | $102 |
| Neurocrine Biosciences, Inc. | 2 | $56 |
| Genentech USA, Inc. | 2 | $37 |
| Indivior Inc. | 2 | $32 |
| Theratechnologies Inc. | 2 | $29 |
| Novo Nordisk | 1 | $25 |
| Amgen | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$65,079 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 94 | $370,546 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 51 | $251,709 |
| TivicayDolutegravir Sodium | 40 | $88,432 |
| DovatoDolutegravir Sodium/Lamivudine | 29 | $84,736 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 16 | $59,949 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 13 | $47,935 |
| XifaxanRifaximin | 13 | $41,791 |
| JulucaDolutegravir/Rilpivirine | 11 | $38,018 |
| DelstrigoDoravirine/Lamivu/Tenofov Diso | 14 | $36,532 |
| EdurantRilpivirine Hcl | 13 | $18,521 |
| JardianceEmpagliflozin | 20 | $15,344 |
| JanuviaSitagliptin Phosphate | 15 | $8,443 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 14 | $8,414 |
| Abacavir-LamivudineAbacavir Sulfate/Lamivudine | 11 | $8,021 |
| FarxigaDapagliflozin Propanediol | 11 | $6,298 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya | $23,126 | $430,495110 claims |
| Viiv Healthcare CompanyTivicay, Dovato, Triumeq, Juluca | $18,822 | $259,12093 claims |
| Janssen Products, LPSymtuza | $13,976 | $251,70951 claims |
| MerckDelstrigo, Januvia | $7,989 | $44,97529 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Philadelphia
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Victoria WongPhiladelphia$51K
- Parth PatelPhiladelphia$46K
- Zachary LutzPhiladelphia$30K
- Hawah MusaPhiladelphia$13K
- Carl BlackPhiladelphia$13K
- Ashley BarratPhiladelphia$12K
- Jacqueline KernaghanSpringfield$426K
- Drew SodaNew Hope$220K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.